CBD isolate may reduce symptoms and progression of Parkinson’s disease – study

New research has shown that CBD may have therapeutic effects on disease progression and treating symptoms in Parkinson’s Disease.

Exploratory research using an accepted, yet experimental, model of Parkinson’s disease found that CBD isolate may improve the symptoms associated with the condition.

It also discovered it is potentially neuroprotective which could decrease disease progression.

CBD isolate from cannabis Sativa L aerial parts, Bod MediCabilis™100 CBD Isolate, was given to animal test subjects for 28 days.

Findings revealed an increase in the survival of the nerve cells normally impacted by the disease along with recovery of motor performance.

The results may help future research into potential therapeutic actions for other motor neurone diseases.

Jo Patterson, CEO of Bod said: “We are excited by this new research and the discovery of the mode of action of CBD in Parkinson’s disease. This research further supports Bod pharmaceutical cannabis medicines in their therapeutic potential.”

Parkinson’s Disease

In Australia, it is estimated that about 212, 000 people live with Parkinson’s disease. The disease can often be debilitating and has a huge impact on quality of life.

It is estimated that 1 in 37 people living in the UK will be diagnosed with PD. In England alone, there are approximately 121,000 patients.

Parkinson’s causes a loss of dopamine-signalling nerve cells resulting in many symptoms including tremors, muscle rigidity and mood disorders. Other symptoms include impaired posture and balance and loss of automatic movements.

There is currently no treatment to reduce Parkinson’s disease as current treatments focus on reducing or managing symptoms. CBD may provide an alternative treatment to slow the progression.

Parkinson’s and motor-neurone disease

Dr. Adele Hosseini, chief scientific officer of Bod added: “This study supports current research being conducted by Gold Coast University Hospital with Motor Neuron Disease in the use of Bod MediCabilis™ 5 percent CBD which is still open for eligible patients.”

The Gold Coast University Hospital is currently recruiting patients with motor-neurone dais or amyotrophic lateral sclerosis (ALS) for a trial using Bod MediCabilis™ cannabis.

Read more: Medical cannabis may relieve pain in fibromyalgia patients